| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |